These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24474540)

  • 1. Importance of the neutrophil-to-lymphocyte ratio in muscle-invasive and non-muscle invasive bladder tumors.
    Ceylan C; Doluoglu OG; Keleş I; Gazel E; Temuçin T; Odabaş Ö; Karalar M
    Urologia; 2014; 81(2):120-4. PubMed ID: 24474540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma.
    Lee SM; Russell A; Hellawell G
    Korean J Urol; 2015 Nov; 56(11):749-55. PubMed ID: 26568792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative neutrophil-lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer.
    Ma C; Lu B; Diao C; Zhao K; Wang X; Ma B; Lu B; Sun E
    Onco Targets Ther; 2016; 9():4917-22. PubMed ID: 27540305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic values of tumor-infiltrating neutrophils, lymphocytes and neutrophil/lymphocyte rates in bladder urothelial cancer.
    Liu K; Zhao K; Wang L; Sun E
    Pathol Res Pract; 2018 Aug; 214(8):1074-1080. PubMed ID: 29803657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can neutrophil to lymphocyte ratio predict lamina propria invasion in patients with non muscle invasive bladder cancer?
    Cimen HI; Halis F; Saglam HS; Gokce A
    Int Braz J Urol; 2017; 43(1):67-72. PubMed ID: 28124528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Primary Non-muscle-invasive Bladder Cancer.
    D'Andrea D; Moschini M; Gust K; Abufaraj M; Özsoy M; Mathieu R; Soria F; Briganti A; Rouprêt M; Karakiewicz PI; Shariat SF
    Clin Genitourin Cancer; 2017 Oct; 15(5):e755-e764. PubMed ID: 28420564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of neutrophil-lymphocyte ratio and risk scores in non-muscle invasive bladder cancer.
    Aydın M; Bitkin A; Kadıhasanoğlu M; İrkılata L; Akgüneş E; Keleş M; Atilla MK
    Actas Urol Esp (Engl Ed); 2019 Nov; 43(9):503-508. PubMed ID: 31164309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder cancer invasion predictability based on preoperative neutrophil-lymphocyte ratio.
    Kaynar M; Yıldırım ME; Badem H; Caviş M; Tekinarslan E; Istanbulluoğlu MO; Karataş ÖF; Çimentepe E
    Tumour Biol; 2014 Jul; 35(7):6601-5. PubMed ID: 24696263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative neutrophil to lymphocyte ratio improves recurrence prediction of non-muscle invasive bladder cancer.
    Getzler I; Bahouth Z; Nativ O; Rubinstein J; Halachmi S
    BMC Urol; 2018 Oct; 18(1):90. PubMed ID: 30348146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative neutrophil-to-lymphocyte ratio (NLR) may be predictive of pathologic stage in patients with bladder cancer larger than 3 cm.
    Celik O; Akand M; Keskin MZ; Yoldas M; Ilbey YO
    Eur Rev Med Pharmacol Sci; 2016; 20(4):652-6. PubMed ID: 26957266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-Lymphocyte Ratio and Pathological Response to Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer.
    Seah JA; Leibowitz-Amit R; Atenafu EG; Alimohamed N; Knox JJ; Joshua AM; Sridhar SS
    Clin Genitourin Cancer; 2015 Aug; 13(4):e229-e233. PubMed ID: 25777682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study.
    Favilla V; Castelli T; Urzì D; Reale G; Privitera S; Salici A; Russo GI; Cimino S; Morgia G
    Int Braz J Urol; 2016; 42(4):685-93. PubMed ID: 27564278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy.
    Kawahara T; Furuya K; Nakamura M; Sakamaki K; Osaka K; Ito H; Ito Y; Izumi K; Ohtake S; Miyoshi Y; Makiyama K; Nakaigawa N; Yamanaka T; Miyamoto H; Yao M; Uemura H
    BMC Cancer; 2016 Mar; 16():185. PubMed ID: 26944862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer.
    Mano R; Baniel J; Shoshany O; Margel D; Bar-On T; Nativ O; Rubinstein J; Halachmi S
    Urol Oncol; 2015 Feb; 33(2):67.e1-7. PubMed ID: 25060672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Immune Cells and Cytokines in the Tumor Microenvironment with Elevated Neutrophil-To-Lymphocyte Ratio in Blood: An Analysis of Muscle-Invasive Bladder Cancer.
    Morizawa Y; Miyake M; Shimada K; Hori S; Tatsumi Y; Nakai Y; Onishi S; Tanaka N; Konishi N; Fujimoto K
    Cancer Invest; 2018; 36(7):395-405. PubMed ID: 30199269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Nonmuscle-Invasive Bladder Cancer Treated with GreenLight Laser Vaporization.
    Luo F; Ma C; Wu J; Li J
    Photobiomodul Photomed Laser Surg; 2019 May; 37(5):312-317. PubMed ID: 31084565
    [No Abstract]   [Full Text] [Related]  

  • 18. Emphasis of neutrophil-to-lymphocyte ratio in non-metastatic renal cell carcinoma.
    Ceylan C; Camtosun A; Doluoglu OG; Tasdemir S; Keles I; Aglamis E; Tatar CA
    Urologia; 2014; 81(1):51-6. PubMed ID: 24474536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancer.
    Ayari C; LaRue H; Hovington H; Caron A; Bergeron A; Têtu B; Fradet V; Fradet Y
    Hum Pathol; 2013 Aug; 44(8):1630-7. PubMed ID: 23574787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment parameters obtained from peripheral blood sample predicts invasiveness of bladder carcinoma.
    Can C; Baseskioglu B; Yılmaz M; Colak E; Ozen A; Yenilmez A
    Urol Int; 2012; 89(4):468-72. PubMed ID: 23128367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.